February 21, 2018 / 8:44 PM / 6 months ago

BRIEF-Astrazeneca Announces Renewed U.S. Recommendation, Availability Of Flumist Quadrivalent Vaccine

Feb 21 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA ANNOUNCES RENEWED RECOMMENDATION AND AVAILABILITY OF FLUMIST QUADRIVALENT VACCINE IN THE US

* ASTRAZENECA - RESULTS DEMONSTRATED NEW 2017-2018 H1N1 LAIV POST-PANDEMIC STRAIN PERFORMED BETTER THAN 2015-2016 H1N1 LAIV POST-PANDEMIC STRAIN​

* ASTRAZENECA - CDC'S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES VOTED IN FAVOR OF RENEWED RECOMMENDATION FOR FLUMIST QUADRIVALENT USE IN U.S. 2018-2019 SEASON Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below